Tag Archives: funding

Perplexed

The good news, I guess, is that we survived another CFS Advisory Committee meeting. The bad news is that much of what happened made no sense to me. Some excellent summaries of the meeting are available, including this very detailed … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , , | 24 Comments

Drug and FDA News, May 2013

Yesterday, the CFIDS Association formally announced what had been rumored to be on the way: they are preparing to file an Investigational New Drug application. The first step will be a pre-IND meeting with FDA. This kind of meeting is … Continue reading

Posted in Research | Tagged , , , , , , , | 4 Comments

CFSAC Testimony May 2013

I submitted two versions of testimony to the May 22-23, 2013 CFS Advisory Committee meeting. My written testimony can be viewed here.  What follows is the testimony I delivered by telephone this morning: My name is Jennifer Spotila, and I … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , , | 18 Comments

2012 NIH Spending on CFS Studies

Update: This post was revised on October 29, 2016 to correct mathematical errors and update the included research. NIH spending on ME/CFS research has been controversial since I’ve been in advocacy, largely because the funding numbers are so low compared … Continue reading

Posted in Research | Tagged , , , , , , , , , | 11 Comments

Moving On Up

For years, the Pacific Fatigue Lab at the University of the Pacific has done the best research on exercise and ME/CFS. Staci Stevens, Dr. Chris Snell, and their collaborators perfected the use of two-day cardio-pulmonary exercise testing (CPET) in people … Continue reading

Posted in Occupying, Research | Tagged , , , , , , , , | 1 Comment

Research Recommendations

See Part One – Tangled Web See Part Two – CFSAC Specific Recommendations See Part Three – Care and Services Recommendations See Part Four – Education and Training Recommendations Appropriately enough, the CSFAC has made more recommendations on research than … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , , | 1 Comment

NIH Collaboration

The news didn’t make much of a splash, but NIH recently issued a funding opportunity announcement that could benefit people with CFS. This purpose of this funding opportunity is to support “collaborative translational research projects” aimed at turning basic discoveries … Continue reading

Posted in Research | Tagged , , , , , , , , | Comments Off on NIH Collaboration

CFSAC Testimony of Dr. Joan Grobstein

Dr. Joan Grobstein delivered these comments to the CFS Advisory Committee at its October 3-4, 2012 meeting. She has kindly given me permission to publish them here. Hello.  I’m Dr. Joan Grobstein.  I’m a physician. My topic is responsibility. Recently … Continue reading

Posted in Advocacy | Tagged , , , , , , , , | 4 Comments

Another CFSAC Done Gone

The CFS Advisory Committee held its second meeting of the year on October 3-4, 2012. Last time, I organized my summary around the good, the bad, and the WTF moments. This time, I am organizing around the discussion themes. Overall, … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , , , , , | 16 Comments

Metrics

I delivered the following testimony via telephone to the CFS Advisory Committee on October 3, 2012. I would like to note something that Dr. Nancy Lee said today: “Nothing about me without me.” That’s what we’re asking for. FDA is … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 6 Comments